Results

Looking for more? ProQuest® Dissertations & Theses has additional dissertations and theses.
11411 open access dissertations and theses found for:
if(Lung cancer)  »   Refine Search
1.
β-Cryptoxanthin prevents against carcinogen-initiated and nicotine-promoted lung tumor development and emphysema in A/J mice and the possible mechanisms involved
by Iskandar, Anita Ratnasari, Ph.D.  Tufts University, Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy. 2012: 255 pages; 3505924.
2.
Psychosocial aspects of risk perceptions for cardiovascular disease, breast cancer, and lung cancer in younger and older women
by Hamilton, Jada Gabrielle, Ph.D.  State University of New York at Stony Brook. 2009: 243 pages; 3393647.
3.
Cancer survival with Pan-Asian medicine & vitamins
by McCulloch, Michael Fintan, Ph.D.  University of California, Berkeley. 2008: 250 pages; 3353458.
4.
6.
A Novel Cytokine Response Modulatory Function of MEK Inhibitors Mediates Therapeutic Efficacy
by Xie, Mengyu, Ph.D.  University of South Florida. 2019: 116 pages; 27548291.
8.
Lung CT Radiomics: An Overview of Using Images as Data
by Hawkins, Samuel Hunt, Ph.D.  University of South Florida. 2017: 102 pages; 10633857.
10.
11.
The Role of KLF6 Gene in Lung Cancer
by Sangodkar, Jaya, Ph.D.  Icahn School of Medicine at Mount Sinai. 2012: 144 pages; 3553575.
12.
A study on lung cancer mortality among an in-patient sample
by Rashid, Asad, M.H.A.  California State University, Long Beach. 2010: 57 pages; 1490331.
13.
Using Supervised Machine Learning for Early Lung Cancer Detection
by Vo, Jessica, M.S.  California State University, Long Beach. 2020: 76 pages; 27736286.
14.
The role of the EphB4 receptor tyrosine kinase in lung cancer
by Ferguson, Benjamin David, Ph.D.  The University of Chicago. 2011: 169 pages; 3472845.
16.
Autophagy Inhibition in Non-small Cell Lung Cancer
by Solitro, Abigail Rae, Ph.D.  Van Andel Research Institute. 2018: 204 pages; 10829750.
17.
Lymphatic pump treatment enhances pulmonary immunity and inhibits solid tumor formation in the lung
by Pedrueza, Mayela, M.S.  University of North Texas Health Science Center at Fort Worth. 2009: 53 pages; 1473681.
18.
MHC II cell based immunotherapy for non-small cell lung cancer in the presence of immune suppression
by Srivastava, Minu Kumari, Ph.D.  University of Maryland, Baltimore County. 2009: 240 pages; 3371813.
19.
Racial, Socioeconomic, and Demographic Disparities Affecting Lung Cancer Screening: A Population-based Analysis
by Alsaggaf, Mohammed, M.S.  Icahn School of Medicine at Mount Sinai. 2019: 32 pages; 13897395.
20.
EGFR Rearrangements as Oncogenic Drivers and Therapeutic Targets in Lung Cancer
by Gallant, Jean-Nicolas, Ph.D.  Vanderbilt University. 2017: 127 pages; 10753387.
21.
23.
Histone deacetylase 6 functions in non-small cell lung cancer
by Deskin, Brian J., Ph.D.  Tulane University. 2016: 154 pages; 10195328.
24.
Gender, social support and coping in online prostate, breast and lung cancer support forums
by Imbesi, Elizabeth Andrea Swigar, Ph.D.  State University of New York at Buffalo. 2011: 109 pages; 3475329.
25.
Impact of BET Bromodomain Inhibition on KRAS-Mutated Non-small Cell Lung Cancer
by Klingbeil, Olaf, Ph.D.  Humboldt Universitaet zu Berlin (Germany). 2016: 152 pages; 10734132.
1 - 30 of 11411 displayed.
  1    2    3    4    5    6    7    8    9    10    11   Next >
Copyright © 2020 ProQuest LLC. All rights reserved. Terms and Conditions Privacy Policy Cookie Policy
ProQuest